Table 3.
All patients | pT3‐4N1M0 | pT1‐2N1M0 | |||||||
---|---|---|---|---|---|---|---|---|---|
S 229 | PORT 246 | P | S 149 | PORT 171 | P | S 80 | PORT 75 | P | |
Locoregional recurrence | 116 (50.7%) | 61 (24.8%) | <0.001 | 80 (53.7%) | 42 (24.6%) | <0.001 | 36 (45%) | 19 (25.3%) | 0.011 |
Supraclavicular | 32 (14%) | 10 (4.1%) | <0.001 | 25 (16.8%) | 7 (4.1%) | <0.001 | 7 (8.8%) | 3 (4%) | 0.229 |
Anastomotic | 9 (3.9%) | 8 (3.3%) | 0.691 | 8 (5.4%) | 6 (3.5%) | 0.417 | 1 (1.3%) | 2 (2.7%) | 0.522 |
Mediastinum | 75 (32.8%) | 34 (13.8%) | <0.001 | 56 (37.6%) | 21 (12.3%) | <0.001 | 19 (23.8%) | 13 (17.3%) | 0.324 |
Celiac | 18 (7.9%) | 15 (6.1%) | 0.450 | 9 (6%) | 12 (7%) | 0.725 | 9 (11.3%) | 3 (4%) | 0.091 |
Hematogenous metastasis | 56 (24.5%) | 81 (32.9%) | 0.042 | 37 (24.8%) | 64 (37.4%) | 0.016 | 19 (23.8%) | 17 (22.7%) | 0.873 |